OLMISTRUM 20 H

Description

OLMISTRUM 20 H is a fixed-dose combination medication that contains Olmesartan Medoxomil 20 mg and Hydrochlorothiazide (HCTZ). This dual-action tablet is formulated to effectively manage high blood pressure (hypertension), especially in patients who do not achieve optimal control with monotherapy alone. Manufactured by Steris Healthcare, OLMISTRUM 20 H is designed to deliver reliable blood pressure control, reduce cardiovascular risk, and promote better compliance in long-term hypertension management. What is Olmesartan Medoxomil and Hydrochlorothiazide? Olmesartan Medoxomil is an angiotensin II receptor blocker (ARB). It works by relaxing blood vessels so that blood can flow more easily, which helps in reducing high blood pressure. Hydrochlorothiazide is a thiazide diuretic, often referred to as a “water pill“. It helps the body eliminate excess salt and water through urine, which further aids in lowering blood pressure. Together in OLMISTRUM 20 H, these two components provide a synergistic antihypertensive effect, making it ideal for patients who need more than one agent to reach target blood pressure levels. Uses of OLMISTRUM 20 H OLMISTRUM 20 H is primarily prescribed for: Management of essential hypertension (high blood pressure of unknown cause) Patients inadequately controlled on olmesartan or hydrochlorothiazide alone Reducing the risk of stroke, heart attack, or kidney damage related to chronic high blood pressure Effective blood pressure control with OLMISTRUM 20 H helps protect vital organs like the heart, brain, and kidneys from long-term damage. Side Effects of Olmesartan Medoxomil and Hydrochlorothiazide Most side effects are mild and manageable. However, patients should be aware of potential adverse effects: Common Side Effects: Dizziness or light-headedness (especially when standing up) Headache Increased urination Weakness or tiredness Nausea Less Common but Serious Side Effects: Electrolyte imbalances (low potassium or sodium) Gout (due to increased uric acid) Kidney dysfunction Skin rash or photosensitivity Hypotension (especially in volume-depleted individuals) Elevated blood sugar or cholesterol levels Patients should be monitored regularly through blood pressure checks, blood tests, and kidney function tests. Precautions Before Using OLMISTRUM 20 H Before starting OLMISTRUM 20 H, patients should take into account the following precautions: Pregnancy and Breastfeeding: Not recommended. Can cause fetal harm. Kidney or Liver Impairment: Dosage adjustment may be required. Electrolyte Imbalance: Monitor sodium, potassium, and magnesium levels periodically. Dehydration or Low Blood Volume: Correct volume before initiating treatment. Diabetes: HCTZ may alter blood glucose control. History of Gout: HCTZ may elevate uric acid levels. Patients should not stop the medication suddenly unless advised by a doctor. Drug Interactions Tell your doctor about all medications, herbal products, or supplements you are taking. Key interactions include: NSAIDs (e.g., ibuprofen): May reduce the effect of OLMISTRUM 20 H and impair kidney function. Lithium: Risk of lithium toxicity when combined with HCTZ. Other antihypertensives: May enhance blood pressure-lowering effects. Potassium supplements or potassium-sparing diuretics: May increase the risk of hyperkalemia with Olmesartan. Antidiabetic medications: HCTZ may reduce their effectiveness. Your doctor may advise regular monitoring of electrolyte levels, renal function, and blood pressure. Why Choose Steris Healthcare’s OLMISTRUM 20 H? Steris Healthcare is committed to providing safe, effective, and affordable solutions for chronic diseases like hypertension. Here’s why OLMISTRUM 20 H stands out: Formulated using international quality standards Proven efficacy of ARB + diuretic combination Reliable and consistent blood pressure control Patient-centric approach to drug design and packaging Trusted brand by physicians across India Steris ensures widespread availability, strong support to healthcare providers, and responsive customer care for all its cardiovascular products.